CATHERINE D MORRIS

Allopathic & Osteopathic Physicians|Internal Medicine CANTON, GA NPI 1619984820

General Payments — all program years on this page

$2,403.04

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 116
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $367.77 across 15 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $367.7715

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Novo Nordisk AS $199.736
Amgen Inc. $66.624
ABBVIE INC. $32.661
GlaxoSmithKline, LLC. $25.011
Phathom Pharmaceuticals, Inc. $15.511
Astellas Pharma US Inc $14.661
Exact Sciences Corporation $13.581

By program year

Program yearAmountRecords
2018 $609.2030
2019 $359.6125
2020 $172.415
2022 $343.5018
2023 $550.5523
2024 $367.7715

Records — PY2024 (15)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096746155 Novo Nordisk Inc $22.51 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096984204 Novo Nordisk Inc $18.48 01/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097102176 Novo Nordisk Inc $15.97 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097361089 Novo Nordisk Inc $104.44 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097414080 Novo Nordisk Inc $16.15 07/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097522734 Novo Nordisk Inc $22.18 08/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105067703 ABBVIE INC. $32.66 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111656197 Amgen Inc. $22.35 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111656199 Amgen Inc. $13.55 10/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111656201 Amgen Inc. $16.29 12/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114797379 Exact Sciences Corporation $13.58 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115730252 GlaxoSmithKline, LLC. $25.01 03/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117333144 Amgen Inc. $14.43 06/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139325040 Astellas Pharma US Inc $14.66 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151098827 Phathom Pharmaceuticals, Inc. $15.51 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.